News for 'Murtaza Khorakiwala'

Drugmakers look to fill Rs 600 cr Novo vacuum

Indian drugmakers Eris Lifesciences, Wockhardt and Lupin are prepping to cash in when Danish company Novo Nordisk bows out of the human insulin pen market by the end of this year and creates an opportunity estimated to be worth Rs 600-800 crore in the domestic market. Some self-use disposable pens are pre-filled with insulin and others can be reused with new cartridges.

Regulator finds procedural lapses at Wockhardt's US facility

The FDA had imposed a ban on the company's Waluj plant in May.

FDA raises concern over US unit: Wockhardt

Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.

Wockhardt's Shendra unit set for key US test

If the company manages to get a go-ahead from the regulator for this plant, it might result in resumption of supplies of several of their products, barred from the US last year.

'You can't succeed without taking risk'

'There are different kinds of risk.' 'It is a very powerful value. Your ability to de-risk the risk is also as important for risk taking.'

Sons rise at Wockhardt

From someone who knows: How to do well in business

'In any business you have to achieve short-term goals.' 'But at the same time you have to keep your broader perspective long term.' 'It is good for business survival.'

'Whatever I have is because of India'

'15, 17 years back we were not even in existence in the US. Today nearly 1/3 of prescriptions written comes from India.' 'India is showing that in a very competitive environment -- like the US and Europe -- our industry is doing very well.'

Next-gen Ambanis, Godrejs see their wealth rise as markets rally

As record stock market rally continues, the value of shares directly owned by next-generation business leaders at 20 major corporate houses has soared over 18 per cent to Rs 17,000 crore.